LDOS heads into the week after its Q1 print badly bruised — down 16% over the past month and still digesting a brutal earnings reaction that sent analysts scrambling to reprice.
The catalyst is hard to miss. On May 5, LDOS fell 9.3% on the day and extended that loss to 13.7% over five sessions, as a weak book-to-bill ratio of 0.8x and staffing headwinds rattled the investment case. At $128.39, the stock trades at a steep discount to where most of the Street was positioned just weeks ago. The next scheduled earnings date is June 2, leaving little time for a narrative reset.
Analyst targets have moved in one direction since the print. This week, Citi's John Godyn — a bellwether voice on the name — kept his Buy but cut his target from $232 to $178, a 23% reduction. RBC Capital and Stifel also moved lower, trimming to $180 and $193 respectively while holding their ratings. BofA and Truist made similar adjustments in late April, before the print landed. The direction of travel is consistent: firms remain broadly constructive on LDOS's long-term positioning in government IT, but the consensus mean target has pulled back to $190, implying roughly 48% upside from current levels — a gap that reflects genuine uncertainty rather than straightforward undervaluation. The bear case centres on a sluggish award environment, competitive pricing pressure from government efficiency initiatives, and normalising VA medical exam margins. Bulls point to the company's diversified customer base and the integration of Entrust as a source of medium-term earnings support.
Options positioning adds a mild layer of caution to an already defensive setup. The put/call ratio has climbed to 0.73, running above its 20-day average of 0.66 — roughly 1.3 standard deviations elevated — though still well short of the 52-week high of 1.40 reached during an earlier stress point. That suggests hedging activity has ticked up since the earnings drop, but options traders are not yet pricing in a further acute move. Short interest reinforces this reading. Shorts have actually been covering: SI % FF dropped nearly 10% on the week to 2.6% of the float, back toward the lower end of the recent range. Cost to borrow has eased 22% over the week to a negligible 0.34%. Availability in the lending market remains extremely loose, with only 1.5% of the pool currently in use against the 52-week peak of 5.5% — there is no borrow squeeze dynamic at play. Taken together, shorts are not pressing the move lower; if anything, the post-earnings dip encouraged some covering.
On valuation, the re-rating has been meaningful. The P/E multiple has compressed nearly 2.4 points over the past 30 days to 10.2x, and the P/B has shed 0.67 to 2.66x — both reflecting the reset in earnings expectations. EV/EBITDA at 8.1x looks undemanding for a company with LDOS's contract backlog profile, and the earnings yield has risen to nearly 10%. The ORTEX factor score on EV/EBIT ranks in the 84th percentile of the universe, suggesting the valuation compression has pushed the stock into territory that screens attractively for value-oriented buyers. The dividend score ranks at the 98th percentile, though the dividend history in the data is stale and should not be taken as a current yield signal.
The insider register offers a small note of context without offering a clear directional read. CEO Tom Bell sold 2,530 shares on May 5 — the same day as the earnings drop — for roughly $376,000, a modest transaction relative to the company's size. Director Gary May sold a similar dollar amount on May 7. Net insider activity over 90 days shows net selling of around $3.5 million across multiple executives, consistent with routine plan-based activity rather than a concentrated signal. The institutional base remains anchored by index heavyweights: Vanguard holds 11.9% and BlackRock 8.2%, with State Street and JP Morgan Asset Management both adding shares in the most recent reporting period.
Among peers, the week has been broadly painful for government services names. KBR fell 12.3% and HURN lost 16.6% over the same period, suggesting LDOS is not an isolated story but part of a sector-wide re-rating. CACI bucked the trend, adding 1% on the week — worth watching as a read on whether the government IT selloff has been indiscriminate.
With June 2 now the next focal point, the stock's trajectory will hinge less on the macro backdrop and more on whether the book-to-bill recovers and management can offer a credible timeline for contract award acceleration.
See the live data behind this article on ORTEX.
Open LDOS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
